Holly-May Lewis

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15

An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics

Matt Spick, Holly-May Lewis, Cécile Frampas et al. · Scientific Reports · 2022 · 36 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +15

Metabolomics Markers of COVID-19 Are Dependent on Collection Wave

Holly-May Lewis, Yufan Liu, Cécile Frampas et al. · Metabolites · 2022 · 30 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +17

Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells

Kyle D. G. Saunders, Johanna von Gerichten, Holly-May Lewis et al. · Analytical Chemistry · 2023 · 28 citations · Full text

Medicine, Cell Biology, Oncology +15